Phase 1 dose‐escalation study of single‐agent veliparib in Japanese patients with advanced solid tumors
暂无分享，去创建一个
T. Shimoi | M. Yunokawa | K. Yonemori | C. Shimizu | K. Tamura | P. Komarnitsky | H. Xiong | S. Yamaguchi | K. Fujiwara | Y. Imai | Koji Matsumoto | Silpa Nuthalapati | T. Onoe | A. Miyasaka | H. Yoshida | T. Nishikawa | T. Leahy | H. Hashiba | T. Kiriyama